Mechanisms of Therapeutic Antitumor Monoclonal Antibodies von Tsao, Li-Chung, Force, Jeremy, Hartman, Zachary C

Volltext

ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer—Comparison of Approaches von Miller, Krislyn N., Thomas, Samantha M., Record, Sydney M., Rosenberger, Laura H., DiNome, Maggie L., DiLalla, Gayle, Force, Jeremy M., Hwang, E. Shelley, Plichta, Jennifer K.

Volltext

Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database von Ong, Cecilia T., Campbell, Brittany M., Thomas, Samantha M., Greenup, Rachel A., Plichta, Jennifer K., Rosenberger, Laura H., Force, Jeremy, Hall, Allison, Hyslop, Terry, Hwang, E. Shelley, Fayanju, Oluwadamilola M.

Volltext

Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading von Force, Jeremy, Leal, Jorge Henrique Santos, McArthur, Heather L.

Volltext

Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches von Miller, Krislyn N., Thomas, Samantha M., Record, Sydney M., Rosenberger, Laura H., DiNome, Maggie L., DiLalla, Gayle, Force, Jeremy M., Hwang, E. Shelley, Plichta, Jennifer K.

Volltext

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors von Iyer, Sudarshan R, Nusser, Kevin, Jones, Kristen, Shinde, Pushkar, Keddy, Clare, Beach, Catherine Z, Aguero, Erin, Force, Jeremy, Shinde, Ujwal, Davare, Monika A

Volltext

Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor von Norden-Zfoni, Anat, Desai, Jayesh, Manola, Judith, Beaudry, Paul, Force, Jeremy, Maki, Robert, Folkman, Judah, Bello, Carlo, Baum, Charles, DePrimo, Sam E, Shalinsky, David R, Demetri, Goerge D, Heymach, John V

Volltext

First-line treatment of metastatic melanoma: role of nivolumab von Force, Jeremy, Salama, April Ks

Volltext

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 von Ademuyiwa, Foluso O., Gao, Feng, Street, Cherease R., Chen, Ina, Northfelt, Donald W., Wesolowski, Robert, Arora, Mili, Brufsky, Adam, Dees, E. Claire, Santa-Maria, Cesar A., Connolly, Roisin M., Force, Jeremy, Moreno-Aspitia, Alvaro, Herndon, John M., Carmody, Madelyn, Davies, Sherri R., Larson, Sarah, Pfaff, Kathleen L., Jones, Stephanie M., Weirather, Jason L., Giobbie-Hurder, Anita, Rodig, Scott J., Liu, Zheng, Hagemann, Ian S., Sharon, Elad, Gillanders, William E.

Volltext

Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications... von BEAUDRY, Paul, FORCE, Jeremy, NAUMOV, George N, WANG, Andrew, BAKER, Cheryl H, RYAN, Anderson, SOKER, Shay, JOHNSON, Bruce E, FOLKMAN, Judah, HEYMACH, John V

Volltext

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium von Devi, Gayathri R, Hough, Holly, Barrett, Nadine, Cristofanilli, Massimo, Overmoyer, Beth, Spector, Neil, Ueno, Naoto T, Woodward, Wendy, Kirkpatrick, John, Vincent, Benjamin, Williams, Kevin P, Finley, Charlotte, Duff, Brandi, Worthy, Valarie, McCall, Shannon, Hollister, Beth A, Palmer, Greg, Force, Jeremy, Westbrook, Kelly, Fayanju, Oluwadamilola, Suneja, Gita, Dent, Susan F, Hwang, E Shelley, Patierno, Steven R, Marcom, P Kelly

Volltext

Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin von GIRNUN, Geoffrey D, LIANG CHEN, NASERI, Elnaz, BUCKLEY, Stephanie, DANAN LI, FORCE, Jeremy, MCNAMARA, Kate, DEMETRI, George, SPIEGELMAN, Bruce M, WONG, Kwok-Kin, SILVAGGI, Jessica, DRAPKIN, Ronny, CHIRIEAC, Lucian R, PADERA, Robert F, UPADHYAY, Rabi, VAFAI, Scott B, WEISSLEDER, Ralph, MAHMOOD, Umar

Volltext

Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer von Isaacs, James, Anders, Carey, McArthur, Heather, Force, Jeremy

Volltext

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the Na... von Fayanju, Oluwadamilola M, Ren, Yi, Thomas, Samantha M, Greenup, Rachel A, Plichta, Jennifer K, Rosenberger, Laura H, Tamirisa, Nina, Force, Jeremy, Boughey, Judy C, Hyslop, Terry, Hwang, E Shelley

Volltext

Mechanisms of therapeutic anti-tumor monoclonal antibodies von Tsao, Li-Chung, Force, Jeremy, Hartman, Zachary C.

Volltext

Clinical trials of self-replicating RNA-based cancer vaccines von Morse, Michael A., Crosby, Erika J., Force, Jeremy, Osada, Takuya, Hobeika, Amy C., Hartman, Zachary C., Berglund, Peter, Smith, Jonathan, Lyerly, H. Kim

Volltext

Advancing TNBC care in the community oncology practice: Insights from a quality improvement initiative von Force, Jeremy Meyer, Rugo, Hope S., Sullivan, Shelby, Dewald, Ilona, Carter, Jeffrey D., Heggen, Cherilyn, McKinnon, Kelly E.

Volltext

Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced... von Burnette, Sarah E., Poehlein, Emily, Lee, Hui-Jie, Force, Jeremy, Westbrook, Kelly, Moore, Heather N.

Volltext

The budget impact of utilizing the Oncotype DX Breast Recurrence Score® test from a US healthcare payer perspective von Berdunov, Vladislav, Laws, Ewan, Cuyun Carter, Gebra, Luo, Roger, Russell, Christy, Campbell, Sara, Force, Jeremy, Abdou, Yara

Volltext

Abstract PS13-33: Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuz... von Moore, Heather, Shofer, Scott, Guisinger, Amy, Broadwater, Gloria, Force, Jeremy, Sammons, Sarah, Anders, Carey, Westbrook, Kelly

Volltext